Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Basel, Switzerland-based Novartis may sell its eye care business Alcon, reports Reuters.
Air maintenance workers at United Parcel Service voted to authorize a strike after three years of unsuccessful contract negations over health benefits, reports Reuters.
The Food and Drug Administration approved Dublin-based Medtronic's Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator for patients with heart failure.
President-elect Donald Trump could significantly affect the Food and Drug Administration's oversight of the drug industry, according to John LaMattina, former president of Pfizer Global Research and Development.
Stericycle ExpertSOLUTIONS recently released its report on U.S. product recalls for the third quarter of this year.
As everyone who is familiar with hospital financials knows, supplies are the second largest operating expense for a health system, after labor costs.
Rob Austin, Associate Director, Healthcare Performance Excellence Practice, Navigant Consulting
Four healthcare industry experts discuss how President-elect Donald Trump's healthcare policies could affect the medical device and pharmaceutical industries.
The Food and Drug Administration recently rejected Dynavax Technology Corp.'s hepatitis B drug, Heplisav-B, for the second time in three years, reports Reuters.
The Food and Drug Administration recently granted priority review status to Novartis' experimental leukemia drug midostaurin, reports Reuters.
The Cubs' World Series win last week conveniently allowed sporting apparel retailer Fanatics to practice managing higher-than-normal consumer demands before the holiday season's expected surge in orders, reports The Wall Street Journal.